Your browser doesn't support javascript.
loading
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.
Cele, Sandile; Karim, Farina; Lustig, Gila; San, James Emmanuel; Hermanus, Tandile; Tegally, Houriiyah; Snyman, Jumari; Moyo-Gwete, Thandeka; Wilkinson, Eduan; Bernstein, Mallory; Khan, Khadija; Hwa, Shi-Hsia; Tilles, Sasha W; Singh, Lavanya; Giandhari, Jennifer; Mthabela, Ntombifuthi; Mazibuko, Matilda; Ganga, Yashica; Gosnell, Bernadett I; Karim, Salim S Abdool; Hanekom, Willem; Van Voorhis, Wesley C; Ndung'u, Thumbi; Lessells, Richard J; Moore, Penny L; Moosa, Mahomed-Yunus S; de Oliveira, Tulio; Sigal, Alex.
  • Cele S; Africa Health Research Institute, Durban, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Karim F; Africa Health Research Institute, Durban, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Lustig G; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.
  • San JE; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Hermanus T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa; Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
  • Snyman J; Africa Health Research Institute, Durban, South Africa; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
  • Moyo-Gwete T; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Wilkinson E; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa; Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
  • Bernstein M; Africa Health Research Institute, Durban, South Africa.
  • Khan K; Africa Health Research Institute, Durban, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Hwa SH; Africa Health Research Institute, Durban, South Africa; Division of Infection and Immunity, University College London, London, UK.
  • Tilles SW; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Singh L; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Mthabela N; Africa Health Research Institute, Durban, South Africa.
  • Mazibuko M; Africa Health Research Institute, Durban, South Africa.
  • Ganga Y; Africa Health Research Institute, Durban, South Africa.
  • Gosnell BI; Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • Karim SSA; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
  • Hanekom W; Africa Health Research Institute, Durban, South Africa; Division of Infection and Immunity, University College London, London, UK.
  • Van Voorhis WC; Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Ndung'u T; Africa Health Research Institute, Durban, South Africa; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
  • Lessells RJ; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
  • Moore PL; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the
  • Moosa MS; Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • de Oliveira T; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa; Centre for Epidemic Response and In
  • Sigal A; Africa Health Research Institute, Durban, South Africa; School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa; Max Planck Institute for Infection Biology, Berlin, Germany. Electronic address: alex.sigal@ahri.org.
Cell Host Microbe ; 30(2): 154-162.e5, 2022 02 09.
Article en En | MEDLINE | ID: mdl-35120605

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Anticuerpos Neutralizantes / Evasión Inmune / Inmunogenicidad Vacunal / SARS-CoV-2 / Vacuna BNT162 Límite: Adult / Animals / Female / Humans País como asunto: Africa Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Anticuerpos Neutralizantes / Evasión Inmune / Inmunogenicidad Vacunal / SARS-CoV-2 / Vacuna BNT162 Límite: Adult / Animals / Female / Humans País como asunto: Africa Idioma: En Año: 2022 Tipo del documento: Article